DB Fitzpatrick & Co Inc Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

DB Fitzpatrick & Co Inc bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,658 shares of the healthcare conglomerate’s stock, valued at approximately $839,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Delta Financial Group Inc. grew its holdings in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares during the period. First PREMIER Bank increased its position in UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 18 shares in the last quarter. Genesee Capital Advisors LLC boosted its holdings in UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after acquiring an additional 18 shares in the last quarter. Jmac Enterprises LLC increased its holdings in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after acquiring an additional 18 shares in the last quarter. Finally, Matrix Private Capital Group LLC grew its position in UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE:UNH opened at $510.03 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a fifty day moving average of $551.50 and a 200 day moving average of $562.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on UNH shares. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday. Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, UBS Group decreased their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.